The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy

被引：61

作者：

Leone, Kevin ^{[1
]}

Poggiana, Cristina ^{[1
]}

Zamarchi, Rita ^{[1
]}

机构：

[1] Veneto Inst Oncol IOV IRCCS, Padua, Italy

来源：

DIAGNOSTICS | 2018年 / 8卷 / 03期

关键词：

circulating tumor cells; immune system; immunotherapy; cancer biomarkers; liquid biopsy; metastasis; EPITHELIAL-MESENCHYMAL TRANSITION; NEUTROPHIL EXTRACELLULAR TRAPS; METASTATIC BREAST-CANCER; PLASMACYTOID DENDRITIC CELLS; REGULATORY T-CELLS; MONOCLONAL-ANTIBODY THERAPY; FACILITATE LUNG METASTASIS; GR-1+CD11B+ MYELOID CELLS; NATURAL-KILLER-CELLS; COLORECTAL-CANCER;

D O I：

10.3390/diagnostics8030059

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Circulating tumor cells (CTCs) have aroused increasing interest not only in mechanistic studies of metastasis, but also for translational applications, such as patient monitoring, treatment choice, and treatment change due to tumor resistance. In this review, we will assess the state of the art about the study of the interactions between CTCs and the immune system. We intend to analyze the impact that the cells of the immune system have in limiting or promoting the metastatic capability of CTCs. To this purpose, we will examine studies that correlate CTCs, immune cells, and patient prognosis, and we will also discuss relevant animal models that have contributed to the understanding of the mechanisms of immune-mediated metastasis. We will then consider some studies in which CTCs seem to play a promising role in monitoring cancer patients during immunotherapy regimens. We believe that, from an accurate and profound knowledge of the interactions between CTCs and the immune system, new immunotherapeutic strategies against cancer might emerge in the future.

引用

页数：46

共 258 条

[21] A pooled analysis of bone marrow micrometastasis in breast cancer [J].

Braun, S ;

Vogl, FD ;

Naume, B ;

Janni, W ;

Osborne, MP ;

Coombes, RC ;

Schlimok, G ;

Diel, IJ ;

Gerber, B ;

Gebauer, G ;

Pierga, JY ;

Marth, C ;

Oruzio, D ;

Wiedswang, G ;

Solomayer, EF ;

Kundt, G ;

Strobl, B ;

Fehm, T ;

Wong, GYC ;

Bliss, J ;

Vincent-Salomon, A ;

Pantel, K .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (08) :793-802

[22]

Braun S, 1999, CLIN CANCER RES, V5, P3999

[23] Perforin-dependent direct cytotoxicity in natural killer cells induces considerable knockdown of spontaneous lung metastases and computer modelling-proven tumor cell dormancy in a HT29 human colon cancer xenograft mouse model [J].

Brodbeck, Tobias ;

Nehmann, Nina ;

Bethge, Anja ;

Wedemann, Gero ;

Schumacher, Udo .

MOLECULAR CANCER, 2014, 13

[24] CTLA-4 and PD-1 Pathways Similarities, Differences, and Implications of Their Inhibition [J].

Buchbinder, Elizabeth I. ;

Desai, Anupam .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (01) :98-106

[25] Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications [J].

Cabioglu, N. ;

Sahin, A. A. ;

Morandi, P. ;

Meric-Bernstam, F. ;

Islam, R. ;

Lin, H. Y. ;

Bucana, C. D. ;

Gonzalez-Angulo, A. M. ;

Hortobagyi, G. N. ;

Cristofanilli, M. .

ANNALS OF ONCOLOGY, 2009, 20 (06) :1013-1019

[26] Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma [J].

Callea, Marcella ;

Albiges, Laurence ;

Gupta, Mamta ;

Cheng, Su-Chun ;

Genega, Elizabeth M. ;

Fay, Andre P. ;

Song, Jiaxi ;

Carvo, Ingrid ;

Bhatt, Rupal S. ;

Atkins, Michael B. ;

Hodi, F. Stephen ;

Choueiri, Toni K. ;

McDermott, David F. ;

Freeman, Gordon J. ;

Signoretti, Sabina .

CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10) :1158-1164

[27] Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells [J].

Chan, Keith Syson ;

Espinosa, Inigo ;

Chao, Mark ;

Wong, David ;

Ailles, Laurie ;

Diehn, Max ;

Gill, Harcharan ;

Presti, Joseph, Jr. ;

Chang, Howard Y. ;

van de Rijn, Matt ;

Shortliffe, Linda ;

Weissman, Irving L. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (33) :14016-14021

[28] Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy [J].

Chao, Mark P. ;

Tang, Chad ;

Pachynski, Russell K. ;

Chin, Robert ;

Majeti, Ravindra ;

Weissman, Irving L. .

BLOOD, 2011, 118 (18) :4890-4901

[29] EpCAM an immunotherapeutic target for gastrointestinal malignancy: current experience and future challenges [J].

Chaudry, M. A. ;

Sales, K. ;

Ruf, P. ;

Lindhofer, H. ;

Winslet, M. C. .

BRITISH JOURNAL OF CANCER, 2007, 96 (07) :1013-1019

[30] CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3 [J].

Chen, Jingqi ;

Yao, Yandan ;

Gong, Chang ;

Yu, Fengyan ;

Su, Shicheng ;

Chen, Jianing ;

Liu, Bodu ;

Deng, Hui ;

Wang, Fengsong ;

Lin, Ling ;

Yao, Herui ;

Su, Fengxi ;

Anderson, Karen S. ;

Liu, Qiang ;

Ewen, Mark E. ;

Yao, Xuebiao ;

Song, Erwei .

CANCER CELL, 2011, 19 (04) :541-555

← 1 2 3 4 5 6 7 8 9 10 →